|
1
|
Pentraxin 3 and Platelet Activation in Obese Patients After Gastric Banding.
|
Circ J
|
2015
|
1.39
|
|
2
|
Soluble forms of RAGE in human diseases: clinical and therapeutical implications.
|
Curr Med Chem
|
2009
|
1.18
|
|
3
|
Biomarkers of platelet activation in acute coronary syndromes.
|
Thromb Haemost
|
2012
|
0.94
|
|
4
|
Platelet function in health and disease: from molecular mechanisms, redox considerations to novel therapeutic opportunities.
|
Antioxid Redox Signal
|
2012
|
0.88
|
|
5
|
Plasma levels of soluble CD36, platelet activation, inflammation, and oxidative stress are increased in type 2 diabetic patients.
|
Free Radic Biol Med
|
2012
|
0.83
|
|
6
|
Thromboxane receptors antagonists and/or synthase inhibitors.
|
Handb Exp Pharmacol
|
2012
|
0.81
|
|
7
|
Determinants of thromboxane biosynthesis in rheumatoid arthritis: Role of RAGE and oxidant stress.
|
Free Radic Biol Med
|
2010
|
0.81
|
|
8
|
Inflammation, oxidative stress and platelet activation in aspirin-treated critical limb ischaemia: beneficial effects of iloprost.
|
Thromb Haemost
|
2010
|
0.81
|
|
9
|
Effects of high-amount-high-intensity exercise on in vivo platelet activation: modulation by lipid peroxidation and AGE/RAGE axis.
|
Thromb Haemost
|
2013
|
0.80
|
|
10
|
Variability in the response to antiplatelet treatment in diabetes mellitus.
|
Prostaglandins Other Lipid Mediat
|
2012
|
0.77
|
|
11
|
Soluble CD40L in Mediterranean Spotted Fever: relation to oxidative stress and platelet activation.
|
Thromb Res
|
2009
|
0.76
|